Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies

Chinese Medical Journal - Pulmonary and Critical Care Medicine(2025)10.1016/j.pccm.2025.05.002Source: DataRank Database

Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies is a research paper published in Chinese Medical Journal - Pulmonary and Critical Care Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.65)OA: hybridTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Cungui Mao ORCID

Live enrichment

PubMed:40677415 PMC:PMC12266267 OpenAlex:https://openalex.org/W4411296253

National Institutes of Health National Cancer Institute

Grant: R01CA273263

National Institutes of Health National Cancer Institute

Grant: P01CA097132

National Institutes of Health

Grant: 5R01CA273263-03

Role of ACER2 in cancer chemoresistance and metastasis

National Institutes of Health

Grant: 5P01CA097132-02

Sphingolipids in Cancer Therapy and Angiogenesis

National Institutes of Health

FWCI

4.65

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.pccm.2025.05.002

publisherhttps://doi.org/10.1016/j.pccm.2025.05.002

publisherhttps://api.elsevier.com/content/article/PII:S2772558825000295?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772558825000295?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40677415

Fields of Study

Sphingolipid Metabolism and SignalingEndoplasmic Reticulum Stress and DiseaseATP Synthase and ATPases Research03 medical and health sciences0302 clinical medicine

Keywords

SphingolipidLung cancerCancer researchCancerAutophagyMedicineBiologyInternal medicineCell biologyGeneticsApoptosisMetabolismImmunotherapyBiomarkerChemotherapyChemoresistanceReview Article

Sustainable Development Goals

SDG 0: Good health and well-being

Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies

FAIR Checklist

Authors (1)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)